Safety Experience from Long-Term Treatment with Omeprazole
S. Joelson(AstraZeneca (Sweden)), Mari‐Ann Wallander(Uppsala University), Per Lundborg(AstraZeneca (Sweden)), A. Walan(Linköping University), I.-B. Joelson(AstraZeneca (Sweden))
Cited by 51
Related Papers
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
|Gastroenterology|2000|544
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
|New England Journal of Medicine|1989|382
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis
|British journal of surgery|2007|171
MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINE
|The Lancet|1978|170